Provided by: Chunghwa Chemical Synthesis & Biotech Co.,Ltd
SEQ_NO
2
Date of announcement
2022/06/28
Time of announcement
16:04:17
Subject
Announcement of the change of Spokesperson,
Acting spokesperson.
Date of events
2022/06/28
To which item it meets
paragraph 8
Statement
1.Type of personnel changed (please enter: spokesperson, acting
spokesperson, important personnel (CEO, COO, CMO, CSO, etc.)
,financial officer, accounting officer, corporate governance officer,
research and development officer, chief internal auditor, or
designated and non-designated representatives):
Spokesperson, Acting spokesperson
2.Date of occurrence of the change:2022/06/28
3.Name, title, and resume of the previous position holder:
Spokesperson：Kuan-Chieh Wang/Finance Manager ,
Chunghwa Chemical Synthesis & Biotech Co., Ltd.
Acting spokesperson：Ying-Chi Chen/ Vice President of Sales Division,
Chunghwa Chemical Synthesis & Biotech Co., Ltd.
4.Name, title, and resume of the new position holder:
Spokesperson：Ying-Chi Chen/ Vice President of Sales Division,
Chunghwa Chemical Synthesis & Biotech Co., Ltd.
Acting spokesperson：Kuan-Chieh Wang/Finance Manager ,
Chunghwa Chemical Synthesis & Biotech Co., Ltd.
5.Type of the change (please enter: "resignation", "position
adjustment", "dismissal", "retirement", "death" or "new
replacement"):position adjustment
6.Reason for the change:position adjustment
7.Effective date:2022/06/28
8.Any other matters that need to be specified:None
Attachments
Original Link
Original Document
Permalink
Disclaimer
Chunghwa Chemical Synthesis & Biotech Co. Ltd. published this content on 28 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 June 2022 08:20:07 UTC.
CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. is a Taiwan-based company principally engaged in the manufacture and distribution of biotechnology products and chemical synthetic products. The Company's biotechnology products include pravastatin, rapamycin, tacrolimus, everolimus, mycophenolate mofetil, mycophenolic acid sodium and others. Its non-biotechnology products include methocarbamol, guaifenesin, trandolapril, fluconazole, olopatadine, dexbromopheniramine maleate and glipizide, among others. Its products are applied in the manufacture of drugs for treatment of cough, diabetes, cardiovascular diseases, high blood pressure and immune system diseases. The Company distributes its products within domestic market and to overseas markets, including the rest of Asia, the Americas and Europe.
CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. 
